| |
| |
|
| Insider
Information: |
Sarin Aradhana |
| Relationship: |
EVP, CFO |
| City: |
Bethlehem |
| State: |
PA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
16,865 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$89,722 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
16,865 |
|
|
| Total
Value |
$89,722 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Orasure Technologies Inc |
OSUR |
|
2019-05-21 |
16,865 |
2018-05-08 |
0 |
Premium* |
|
|
Alexion Pharmaceuticals Inc |
ALXN |
EVP, CFO |
2021-07-21 |
0 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
16 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ALXN |
Alexion Pharmaceuticals I... |
EVP, CFO |
• – – |
2021-07-21 |
4 |
D |
$0.00 |
$0 |
D/D |
(120,253) |
0 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
EVP, CFO |
• – – |
2021-07-14 |
4 |
A |
$0.00 |
$0 |
D/D |
56,313 |
120,253 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
EVP, CFO |
• – – |
2021-02-28 |
4 |
A |
$0.00 |
$0 |
D/D |
24,473 |
63,940 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
EVP, CFO |
• – – |
2020-12-16 |
4 |
D |
$157.96 |
$1,478,979 |
D/D |
(9,363) |
39,467 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
EVP, CFO |
• – – |
2020-12-16 |
4 |
A |
$0.00 |
$0 |
D/D |
15,371 |
48,830 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
EVP, CFO |
• – – |
2020-11-30 |
4 |
D |
$124.00 |
$160,952 |
D/D |
(1,298) |
33,459 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
EVP, CFO |
• – – |
2020-03-02 |
4 |
D |
$90.54 |
$79,947 |
D/D |
(883) |
34,757 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
EVP, CFO |
• – – |
2020-02-28 |
4 |
A |
$0.00 |
$0 |
D/D |
10,880 |
35,640 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
EVP, CFO |
• – – |
2019-12-02 |
4 |
D |
$113.20 |
$615,921 |
D/D |
(5,441) |
24,760 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
Chief Strategy & Business Off |
• – – |
2019-06-21 |
4 |
AS |
$132.00 |
$76,296 |
D/D |
(578) |
30,201 |
0 |
- |
|
| OSUR |
Orasure Technologies Inc |
Director |
– • – |
2019-05-21 |
4 |
A |
$8.48 |
$104,999 |
D/D |
12,382 |
16,865 |
0 |
- |
|
| OSUR |
Orasure Technologies Inc |
Director |
– • – |
2019-05-06 |
4 |
D |
$9.88 |
$16,415 |
D/D |
(1,661) |
4,483 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
Chief Strategy & Business Off |
• – – |
2019-02-28 |
4 |
A |
$0.00 |
$0 |
D/D |
8,250 |
30,779 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
Chief Strategy & Business Off |
• – – |
2019-02-28 |
4 |
D |
$132.92 |
$35,490 |
D/D |
(267) |
22,529 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
Chief Strategy & Business OffO |
• – – |
2019-02-19 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
22,796 |
|
- |
|
| OSUR |
Orasure Technologies Inc |
Director |
– • – |
2018-05-08 |
4 |
A |
$0.00 |
$0 |
D/D |
6,144 |
6,144 |
0 |
- |
|
16 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
